Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Blood Exposures Survey

The Association of Occupational Health Professionals in Healthcare (AOHP) recently commissioned a survey among its members to establish the first ...read more

Food Safety in Restaurants

Increased awareness and implementation of proper food safety in restaurants and delis may help prevent many of the foodborne illness outbreaks ...read more

Flu Facts

The Centers for Disease Control and Prevention (CDC) provides Frequently Asked Questions (FAQs) on key facts about the 2013-2014 influenza season. ...read more

SSI Prevention

This report explores the prevention of surgical site infections (SSIs) within the context of evidence-based practices replacing "sacred cows" in the ...read more

Biocides and Sporicidal Disinfectants

This Pulse provides a quick summary of some of the ideas and perspectives coming out of the 2013 Spring Conference of the Society of Healthcare ...read more

Latest Headlines

Structure of HIV-Neutralizing Antibody Solved

WASHINGTON -- A team of scientists whose leaders are funded by the National Institutes of Health has solved the structure of an antibody that is able to neutralize HIV, the virus that causes AIDS. Their work is described in the June 27, 2003 issue of Science. The antibody, ...More
June 30, 2003 Posted in News
Vical Receives Grant From NIH for Development of Anthrax Vaccine

SAN DIEGO -- Vical Incorporated today announced that it has been awarded a three-year, $5.7 million Phase II Small Business Innovation Research (SBIR) grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health ...More
June 30, 2003 Posted in News
Vicuron Pharmaceuticals Announces FDA Acceptance for Review of Anidulafungin New Drug Application

KING OF PRUSSIA, Pa. -- Vicuron Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's anidulafungin New Drug Application (NDA) for review. Anidulafungin belongs to the first new class of anti-fungal agents, called ...More
June 30, 2003 Posted in News
Baxa Corporation Introduces PhaSeal, The Only Closed System for Safe Handling of Hazardous Drugs

ENGLEWOOD, Colo. -- Baxa Corporation introduces the only closed system for handling antineoplastic drugs that has been documented to reduce or eliminate human exposure to toxic hazards in the workplace. The new system, called PhaSeal, is manufactured in Sweden by Carmel ...More
June 26, 2003 Posted in News
Abbott Laboratories Sponsors Free HIV Testing Program for Communities at Risk

ABBOTT PARK, Ill. -- According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 3 people in the United States who are HIV positive are unaware of their status. To combat this, Abbott Laboratories has launched a free national HIV testing ...More
June 25, 2003 Posted in News
Circle Group Holdings, Inc. Acquires License to ThraxVac, an Anthrax/Bacterial Spore Collection and Elimination Device

MUNDELEIN, Ill. -- Circle Group Holdings, Inc. announced today that they have acquired the exclusive license to an Anthrax/Bacterial Spore Collection and Elimination device technology developed at the U.S. Department of Energy's Brookhaven National Laboratory, Department of ...More
June 25, 2003 Posted in News
Focus Submits West Nile Virus Diagnostic Kits to FDA for 510(k) Clearance

HERNDON, Va. -- Focus Technologies announces that it has completed clinical trials on its West Nile Virus (WNV) IgG and IgM ELISA diagnostic kits and has filed a 510(k) application with FDA. This is an important development as there are currently no West Nile Virus ...More
June 25, 2003 Posted in News
U.S. Global Aerospace Introduces Nanofilters for Aircraft Environmental Control Systems and Building HVAC Systems

CARSON CITY, Nev. -- US Global Aerospace, Inc. has introduced a new line of virus and pathogen Nanofilters for aircraft Environmental Control Systems (ECS) and Heating, Ventilation and Air Conditioning (HVAC) systems for hospitals and buildings. US Global's Nanofilters are ...More
June 24, 2003 Posted in News, PPE & Standard Precautions
Isis Pharmaceuticals and ITRI of Taiwan Initiate SARS Antisense Drug Discovery Effort

CARLSBAD, Calif., and HSINCHU, Taiwan -- Isis Pharmaceuticals, Inc. and the Industrial and Technology Research Institute (ITRI) of Taiwan announced today that they will collaborate to identify antisense drug candidates targeting the coronavirus associated with Severe Acute ...More
June 24, 2003 Posted in News, PPE & Standard Precautions
New Data Show That Intercept Blood System Inactivates Virus in Same Viral Family as SARS

BRUSSELS, Belgium -- Preliminary test results demonstrate that pathogen inactivation technology is effective against the human coronavirus Subsidiaries of Baxter International Inc. and Cerus Corporation announce preliminary test results demonstrating that the INTERCEPT ...More
June 24, 2003 Posted in News, PPE & Standard Precautions